Thursday, December 26, 2024 12/26/2024

Investigating Pathophysiology of Glioma Stem Cells in 3D Bioprinted Vascularized Glioblastoma Model

Award Number: R21NS121945
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

SUMMARY Glioblastoma multiforme (GBM) is the most lethal primary brain tumor in adults with a 5-year survival rate of less than 5%. GBMs are highly vascular and lethal brain tumors that display cellular hierarchies containing self- renewing and radiotherapy resistant tumorigenic glioma stem cells (GSCs). Understanding of the molecular regulation of GSCs in its native environment is critical for drug development. The available in vitro models suffer from the momentous hurdle of lack of functional blood vessels. Vasculature is not only essential for keeping the tumor alive but also creating a tumor microenvironment that balances the dynamics of GSCs, enabling self-renewal and differentiation. Therefore, there is a significant need for a preclinical tumor model to investigate the progression and the therapeutic resistance nature of GBM tumor, and thereby aid in drug development for the treatment of GBM. The primary goal of this exploratory (R21) proposal is to (a) develop clinically-relevant bioengineered 3D vascularized GBM organoid models and (b) utilize them to interrogate GBM pathobiology. Specifically, 3D bioprinting approach will be used to design perfusable vascular networks with embedded GSC organoids in a brain-like extracellular matrix. This printed structure will have the potential to provide physiologically similar biophysical and biochemical microenvironment with perivascular niches to facilitate maintenance of stemness cues as well as transformation of GSCs into differentiated glioma cells. As ablation of GSCs represents a potential therapeutic approach for treatment of GBM, these bioengineered GBM models can be utilized to understand the molecular regulation of GSCs in a microenvironment mimicking its native surroundings. It is envisioned that these 3D bioprinted vascularized GBM models will not only serve as a powerful platform to study GBM but will serve as invaluable tools for drug screens for precision medicine.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $184,761 )
2023	2023	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	2	2/14/2023	NON-COMPETING CONTINUATION	$18,476
2023	2023	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	12/30/2022	NON-COMPETING CONTINUATION	$166,285
														Subtotal = $184,761

Issue Date FY: 2022 ( Subtotal = $218,462 )
2022	2022	TEXAS A&M UNIVERSITY SYSTEM, THE	8441 RIVERSIDE PARKWAY BLDG 1 STE 3100	BRYAN	TX	77807	BRAZOS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	12/31/2021	NEW	$218,462
														Subtotal = $218,462

Grand Total All Awards = $403,223

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating Pathophysiology of Glioma Stem Cells in 3D Bioprinted Vascularized Glioblastoma Model

Award Number: R21NS121945

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer